Total Funding
65
58
Total FundingVenture - Series Unknown raised
Growth Score 65 in past quarter
-1 pts
Heat Score 58 in past quarter
1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
135566
Airsonett is a research-based medical technology company that develops non-pharmaceutical treatment for allergic asthma.
- Anders Due-Boje: CEO
About the Company
Airsonett is a medical device company that develops treatments for allergic asthma and eczema. The Air4 product from Airsonett is a non-invasive home medical device that relies on patented Temperature-controlled Laminar Airflow technology (TLA). Allergens and other airborne irritants are significantly reduced from the patient's breathing zone
during rest and sleep after treatment with the Airsonett Air4. Airsonett Air4 helps many patients with allergic asthma and atopic eczema, in Sweden and the UK.
